BioTech Finance Recruitment

To secure elite BioTech finance talent in London, firms must identify high-calibre professionals who can navigate the complex intersection of life sciences R&D, patent lifecycles, and high-stakes capital raising. Harper May specialises in placing finance leaders who understand that in the BioTech sector, fiscal management is as much about scientific milestones as it is about the balance sheet.

Ready to future-proof your finance function? Start the conversation with our AI finance recruitment specialists today to ensure your BioTech firm is led by a finance professional with the technical and commercial maturity to drive innovation.

How do London Life Science firms identify the best BioTech finance talent?

The search for excellence in the BioTech space has shifted from generalist accounting to a requirement for specialised industry knowledge. When London-based BioTech firms ask how to find the best finance talent, the answer lies in evaluating a candidate's ability to manage complex grant funding, R&D tax credit claims, and the rigorous due diligence processes required for Series A through to IPO. At Harper May, we utilise a rigorous vetting programme to ensure every candidate understands the nuances of clinical trial accounting and the specific cash-burn profiles of pre-revenue science businesses.

London’s Golden Triangle (London, Oxford, and Cambridge) remains a global powerhouse for life sciences, making the competition for deal-hardened finance specialists exceptionally high. To stand out, companies must hire leaders who can effectively communicate scientific progress to institutional investors and venture capital partners. Our role as a specialist finance recruitment agency is to bridge the gap between these high-growth science labs and the elite tier of professionals who can turn a patent-pending breakthrough into a commercially viable enterprise.

The Strategic Importance of Finance in R&D Heavy Environments

In BioTech, the finance function is the primary gatekeeper of the R&D roadmap. A high-calibre Finance Director or CFO in this sector does more than report on historical spend; they must be able to model multiple scientific outcomes, assess the financial impact of clinical trial delays, and ensure the business has the runway to reach its next valuation inflection point. This requires a level of forward-looking analysis that traditional sectors rarely demand.

Modern BioTech leaders are now expected to oversee international licensing agreements and manage the financial complexities of global partnership deals with Big Pharma. This requires a deep understanding of intellectual property valuation and the ability to work alongside Chief Scientific Officers to align budgetary constraints with laboratory objectives. We specialise in identifying these leaders, ensuring they possess the commercial acumen synonymous with the Harper May brand.

Strategic CFO executive search: CFO Recruitment

Why R&D tax credits and grant management are priorities for BioTech CFOs

For many pre-revenue BioTech firms in London, R&D tax credits represent a vital source of non-dilutive funding. CFOs must possess an expert-level understanding of the latest HMRC guidelines to ensure claims are maximised and audit-proof. We help our clients find the specialists who can lead these complex financial submissions, ensuring every penny of laboratory spend is accounted for.

Official data analytics standards: ICAEW specialist certificates

Furthermore, the Financial Reporting Council (FRC) standards regarding the capitalisation of development costs are particularly relevant in this sector. This means BioTech finance leadership must be technically precise to ensure the balance sheet accurately reflects the company's progress. The candidates we place are well-versed in these requirements, ensuring that your firm’s valuation is built on a foundation of professional financial integrity.

Navigating Equity Raising and Venture Capital Due Diligence

BioTech finance specialists are the architects of the investment deck. They must be able to stress-test financial models against various regulatory approval timelines and market entry scenarios. We look for candidates who have experience in navigating the high-pressure environment of VC due diligence, ensuring that the company’s data room is pristine and that investor queries are met with data-backed confidence.

Our Proven Track Record

Explore our proven track record and successful placements: View our Recent Case Studies.

At Harper May, we believe that factual data and placement metrics are the only true measures of recruitment success. We do not deal in qualitative fluff; we deliver measurable improvements to the stability and funding potential of our BioTech clients. Our history of successful placements across London’s life sciences sector proves our ability to source talent that understands the science of finance.

  • Securing Series B Funding: We successfully placed a CFO for a London-based genomics startup who restructured the financial model to reflect multi-year trial outcomes, leading to a successful £35 million Series B raise.

  • Maximising R&D Returns: A Finance Director we introduced to a mid-market BioTech firm identified £1.2 million in unclaimed R&D tax credits over a two-year period, significantly extending the firm’s operational runway.

  • Global Licensing Structuring: For an oncology-focused research house, our placed CFO successfully negotiated the financial terms of a $100 million global licensing agreement with a top-five pharmaceutical giant.

  • Successful AIM Listing: We recruited a Head of Finance for a disruptive BioTech firm who led the financial preparation and due diligence for a successful listing on the London Stock Exchange’s AIM market.

Verified investment success stories: View our Recent Case Studies

When should a BioTech firm hire a specialist Life Science CFO?

A common question for scaling science businesses is when to transition from a generalist accountant to a specialist Life Science CFO. The answer is usually as soon as the firm prepares for its first institutional funding round. At this stage, investors require a level of financial sophistication that goes beyond basic compliance; they need a leader who can defend the company's valuation through data-driven scientific projections.

Financial planning leadership search: Head of FP&A Recruitment

A specialist CFO builds the financial infrastructure for clinical success. They ensure that grant tracking is automated, that patent costs are correctly capitalised, and that the board has a clear view of the cost-per-milestone. By hiring a leader with a specific BioTech background, firms can avoid the common pitfalls that lead to premature cash-out and lost scientific opportunity.

Ready to secure an exit-ready leader for your business? Explore our available candidates to see the high calibre of leadership we can introduce to your team and secure a finance professional who understands the value of your innovation.

The Impact of Predictive Modelling on BioTech Valuations

In the life sciences sector, the financial model is a living document. Modern BioTech finance leaders are increasingly leveraging predictive analytics to run Monte Carlo simulations on trial success rates. This allows the board to plan for various regulatory outcomes and market adoption speeds, ensuring the business remains agile in the face of scientific uncertainty.

However, the technology is only as good as the professional overseeing it. We focus on placing finance leaders who can bridge the gap between the laboratory and the boardroom, explaining how scientific data impacts the long-term enterprise value of the firm. This level of insight is what separates a Harper May BioTech candidate from a standard corporate accountant.

Bridging the Skills Gap in London’s BioTech Market

There is a significant demand for finance professionals who understand the nuances of the UK's Life Sciences ecosystem. According to the latest Office for National Statistics data, the professional, scientific, and technical activities sector remains one of London's fastest-growing employment areas. Harper May addresses this by maintaining an exclusive network of finance professionals who have transitioned from Big Pharma.

Integrating Intellectual Property into Financial Strategy

Intellectual Property (IP) is the lifeblood of BioTech. A modern Finance Manager in this sector must work closely with patent attorneys to ensure that IP assets are protected and valued correctly on the balance sheet. Our candidates understand the global tax implications of IP holding structures and how to leverage patents for future financing.

Salary Benchmarks for BioTech Finance Roles in 2026

The requirement for professionals who can navigate the complexities of life sciences has driven salaries in the BioTech finance sector to a significant premium. London firms must offer competitive packages that often include substantial equity or milestone-based bonuses.

  • BioTech CFO (Series B/C+): Base salaries ranging from £180,000 to £275,000, plus significant equity.

  • Finance Director (R&D focus): Salaries between £130,000 and £175,000.

  • Financial Controller (Life Sciences): Compensation packages from £95,000 to £125,000.

Private equity compensation data: CFO Salary London

Why Harper May is London’s Premier BioTech Finance Recruiter

Our deep roots in London’s science and technology hubs make Harper May the ideal partner for BioTech firms, venture capital houses, and university spin-outs. We understand that in the world of life sciences, you cannot afford a learning curve for your new finance leader. Our bespoke search process delivers candidates who are ready to contribute to your scientific mission from day one.

Facing a similar challenge? Start the conversation with Harper May today. Contact our finance recruitment team to discuss your exact hiring requirements and secure the elite BioTech leadership your organisation deserves.

Frequently Asked Questions

  1. What makes BioTech finance recruitment different from other sectors? BioTech requires an understanding of pre-revenue valuations, R&D tax credits, and clinical trial cycles. Our specialists focus on candidates with this specific scientific-financial overlap.

  2. Does Harper May recruit for BioTech startups in Oxford and Cambridge? Yes. While our focus is the City, we support the entire Golden Triangle including CFO Recruitment for high-growth labs in Oxford and Cambridge.

  3. What are the key KPIs for a BioTech Finance Manager? Beyond standard cash burn, they track cost-per-clinical-phase, grant utilisation rates, and milestone-weighted valuation metrics.

  4. How do you vet candidates for BioTech commercial experience? We review their funding sheet—their history with VC rounds, grant applications, and successful licensing negotiations with pharma partners.

  5. Where can I find BioTech finance salary data? We update our guides regularly using ONS and internal data. View current trends on our CFO Salary London page.

  6. How long does a BioTech finance search take? Permanent shortlists are typically delivered within 14 days. For urgent requirements, contact the Contact search team immediately.